To organize the world’s digital health products by performance, through clinically crowdsourced data generation.
As a team and company, we see the immense potential of digital health innovation and are obsessed with uncovering fresh opportunities to enable positive healthcare transformation. Our goal is to be the bridge between technology and healthcare to help the most impactful digital health products make it to market quickly and responsibly.
People and community are at the heart of everything we do. We are diverse by design and deeply value diversity of thought, experience, and opinion.
Go fast responsibly
We approach our work with both urgency and diligence. We believe there is a balance between tech’s “go fast and break things” and healthcare’s “do no harm.”
Think bigger, play bigger
We encourage everyone to reimagine how they build the health solutions of the future, thinking and operating beyond traditional boundaries.
Show me the data
We make data-driven decisions. Our vision is to enable every stakeholder in healthcare to do the same, by creating the industry standards and benchmarks.
Meet our executive team
CEO + Founder
Ruby Gadelrab is the CEO and Co-Founder of MDisrupt. She is a seasoned digital health executive with a track record in successfully commercializing healthcare and healthtech products. She served on the executive team at 23andMe as VP of commercial marketing and has worked for many leading companies in the biotech and genetic spaces. Before founding MDisrupt, Ruby consulted for, advised, and mentored more than 25 digital health companies.
Chief Operating Officer
Greg is a seasoned global commercial executive in the life science and medical technology industries. His expertise is in development and execution of go-to-market strategies across the healthcare continuum from provider to patient/consumer. Previously, Greg was chief marketing officer at Drawbridge Health and VP of global marketing at Topcon Eyecare. He also held leadership positions at biotech and medical device companies including Solta Medical, Amgen, Vertex Pharmaceuticals and Aurora Biosciences. Greg received his MBA from Pepperdine University and his BS in Bioengineering from UC San Diego.
VP of Marketing
Mona is a marketing leader with over 15 years b2b experience developing new healthcare markets. Prior to joining MDisrupt, she was an early marketing lead at Invitae Inc, where she helped scale the company from small startup to market leader in the nascent genetic testing industry. She brings with her a deep understanding of global markets from her international marketing work at Invitae and Affymetrix.
Chet Robson, DO, MHCDS, FAAFP
Chief Medical Officer
Dr. Robson is a health industry veteran and former chief clinical officer at Walgreens. He served as medical director of the Walgreens Boots Alliance global pandemic response, working closely with influential healthcare organizations, including the CDC, on COVID-19 testing, vaccines and employee safety. A core part of this role was assessing the clinical integrity of digital health solutions. Dr. Robson obtained his medical degree from Midwestern University and an MBA in healthcare delivery science from the Tuck School of Business and Geisel School of Medicine at Dartmouth College.
VP, Business Development and Partnerships
Kerry is an award-winning leader with expertise in the global health innovation ecosystem and a strong track record in identifying new market segments and launching products. Before joining MDisrupt, she served as VP and executive director for innovation at the Health Information and Management Systems Society. She has a passion for building relationships aimed at accelerating the development and adoption of health technologies and is a proud graduate of the University of Iowa.
Liviu is a highly experienced technology leader who has built solutions at scale for global brands including Netflix, Machine Zone, Yahoo, Net-a-Porter, British Telecom, and British Airways, as well as in the defense and security sectors. With a background in adtech, Liviu’s expertise is in large-scale personalization platforms. He has worked with startups and large enterprises across Europe, the Middle East, and North America, helping them develop and scale their platforms and expand internationally. He has also assisted companies through exits and acquisitions. Liviu advises startups in Silicon Valley, Europe, and the Middle East and mentors through the Endeavor network.
Meet our advisors
Chief Operating Officer, Delfi Diagnostics
Christina Jenkins, MD
Venture Partner, Phoenix Venture Partners
Federico Monzon, MD
President, Genomic Path
Partner, Goodwin (Women’s Health & Wellness, Healthcare & Life Sciences)
Chief Executive Officer, ixLayer
Chief Marketing & Engagement Officer, Teladoc Health